What is Keyview Labs?
Operating under the Procera Health brand, Keyview Labs has established itself as a leader in the cognitive wellness market since its inception in 2005. The company specializes in the development of doctor-formulated supplements designed to enhance memory, mood, and cognitive focus. By prioritizing NSF-certified and FDA-compliant manufacturing processes, the firm addresses the growing consumer demand for transparent, non-GMO, and vegan-friendly brain health solutions. Their market position is defined by a synthesis of clinical rigor and consumer-centric accessibility, allowing them to capture a significant share of the preventative health demographic.
The company's business model relies on a sophisticated supply chain and a commitment to evidence-based product development. By maintaining high standards for ingredient purity and efficacy, Keyview Labs differentiates itself from generic supplement providers, positioning its portfolio as a premium choice for individuals seeking to optimize neurological performance through natural interventions.
How much funding has Keyview Labs raised?
Keyview Labs has raised a total of $665K across 2 funding rounds:
Debt
$150K
Debt
$515K
Debt (2024): $150K with participation from BayFirst National Bank
Debt (2024): $515K, investors not publicly disclosed
Key Investors in Keyview Labs
BayFirst National Bank
A financial institution providing commercial banking services and debt financing solutions to support the growth and operational needs of established enterprises.
Undisclosed Investor
An undisclosed institutional partner participating in the recent debt financing round to bolster the company's capital structure.
What's next for Keyview Labs?
With the recent influx of capital, Keyview Labs is well-positioned to accelerate its strategic initiatives, focusing on market penetration and product diversification. The deployment of these funds will likely prioritize the expansion of their distribution channels and the enhancement of their research and development pipeline to address emerging trends in cognitive health. As the company navigates this growth phase, the focus will remain on scaling operations while maintaining the stringent quality controls that have defined its brand identity. Investors and stakeholders will be monitoring the firm's ability to translate this financial momentum into increased market share and sustained profitability within the broader health and wellness ecosystem.
See full Keyview Labs company page
